7 minute read

Apr. 29, 2024

March 2024 Patent Highlights: OX2R Agonists, TEAD Covalent Inhibitors, NaV1.8 Inhibitors, LRRK2 Inhibitors, and More

Authors:

Vinicius Teixeira,

Shaima Qunies

Reviewer:

Lew Pennington

Editor:

Other articles you may be interested in